Study objective: To investigate the clinical presentation of community-acquired Chlamydia

Size: px
Start display at page:

Download "Study objective: To investigate the clinical presentation of community-acquired Chlamydia"

Transcription

1 Clinical Presentation of Community- Acquired Chlamydia pneumoniae Pneumonia in Adults* Naoyuki Miyashita, MD, PhD; Hiroshi Fukano, MD; Niro Okimoto, MD, PhD, FCCP; Hiroki Hara, MD, PhD, FCCP; Koichiro Yoshida, MD, PhD; Yoshihito Niki, MD, PhD, FCCP; and Toshiharu Matsushima, MD, PhD, FCCP Study objective: To investigate the clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Design: Prospective study. Setting: Kawasaki Medical School Hospital, Kawasaki Medical School Kawasaki Hospital, and Kurashiki Daiichi Hospital in Japan. Participants: Forty patients with community-acquired pneumonia with C pneumoniae as the only pathogen identified admitted to three hospitals between April 1996 and March 2001 and their clinical presentations were compared to patients with Streptococcus pneumoniae and Mycoplasma pneumoniae pneumonia. Measurements: The diagnosis of C pneumoniae infection was based on isolation and serologic testing of antibodies by the microimmunofluorescence test. Results: The clinical presentations, except for shortness of breath, were similar for the three major etiologic agents. The mean temperature of C pneumoniae patients on hospital admission was 37.9 C, which was lower than that of patients with S pneumoniae and M pneumoniae. The mean WBC count on hospital admission was lower in the patients with C pneumoniae (mean, 9,100/ L) than in those with S pneumoniae pneumonia but higher than in those with M pneumoniae pneumonia. No patients required respiratory support or admission to an ICU, and no deaths occurred among the C pneumoniae pneumonia patients. Conclusions: Our results indicate that C pneumoniae pneumonia as a single etiologic agent is mild and that the underlying conditions and clinical symptoms closely resemble those of S pneumoniae pneumonia. However, the physical examinations, laboratory findings, and prognostic factors of the C pneumoniae patients resembled those of patients with M pneumoniae pneumonia. (CHEST 2002; 121: ) Key words: Chlamydia pneumoniae; clinical picture; community-acquired pneumonia; Mycoplasma pneumoniae; Streptococcus pneumoniae Abbreviations: CAP community-acquired pneumonia; CRP C-reactive protein; GPT glutamic pyruvic transaminase *From the Division of Respiratory Diseases (Drs. Miyashita, Fukano, Yoshida, Niki, and Matsushima), Department of Medicine, Kawasaki Medical School; Kawasaki Medical School Kawasaki Hospital (Dr. Okimoto); and Kurashiki Daiichi Hospital (Dr. Hara), Okayama, Japan. Manuscript received May 30, 2001; revision accepted November 14, Correspondence to: Naoyuki Miyashita, MD, PhD, Division of Respiratory Diseases, Department of Internal Medicine, 577 Matsushima, Kurashiki City, Okayama , Japan; nao@med.kawasaki-m.ac.jp Community-acquired pneumonia (CAP) continues to be a major medical problem. Since CAP also is a potentially fatal disease, even in previously healthy persons, early appropriate antibiotic treatment is vital. In Japan, pneumonia is the fourth leading cause of death, and from 57 to 70 persons of 100,000/yr died of this disease during the last decade. 1 Because of this high morbidity, guidelines for CAP management have been created in Japan. 2 However, prospective studies on the etiology of CAP among the Japanese population have been very limited, and the clinical presentations of some etiologic agents including Chlamydia pneumoniae have not been evaluated. C pneumoniae has been established as an important cause of both lower and upper acute respiratory illnesses, including pneumonia, bronchitis, pharyngi Clinical Investigations

2 tis, and sinusitis. 3,4 Studies 4 6 have suggested a possible association of C pneumoniae infection and acute exacerbations of asthma and COPD. Since seroepidemiologic studies 3,4 have demonstrated that 50 to 70% of adults have antibody to C pneumoniae, it is estimated that the majority of the population acquires at least one C pneumoniae infection during their lifetime. Approximately 10% of cases of CAP are associated with C pneumoniae worldwide. 4 In Japan, this organism is the third or fourth leading pathogen in patients with CAP requiring hospital treatment, 7,8 but its incidence (about 7%) is lower than that in Western countries. The most common pathogens in Japan were Streptococcus pneumoniae, accounting for up to 20% of cases, followed by Mycoplasma pneumoniae (9.5%). 8 Because of this high incidence, knowledge of the specific clinical presentation of C pneumoniae pneumonia might be useful in guiding the choice of antibiotic therapy. However, there are no data regarding the clinical presentation of C pneumoniae pneumonia in Japanese adults. Furthermore, previous reports 9 15 have not been entirely in agreement regarding the clinical presentation of C pneumoniae pneumonia. The purposes of this study were to clarify the clinical presentation of C pneumoniae pneumonia in Japan, and to evaluate the newly created Japanese CAP guidelines. We prospectively investigated C pneumoniae pneumonia in hospitalized Japanese adults and compared the results with those of CAP caused by other major pathogens, S pneumoniae and M pneumoniae. These, along with C pneumoniae pneumonia, are the top three etiologies of CAP in Japan. Study Population Materials and Methods All adult patients with CAP who were admitted to Kawasaki Medical School Hospital, Kawasaki Medical School Kawasaki Hospital, and Kurashiki Daiichi Hospital, Okayama, Japan, from April 1996 to March 2001 were enrolled in this study. None of our patients were immunocompromised; that is, patients with HIV infection, patients with neutropenia secondary to chemotherapy or patients receiving immunosuppressants, patients from nursing homes, or patients with recent ( 30 days) hospital admission. The diagnosis was based on clinical signs and symptoms (cough, fever, productive sputum, dyspnea, chest pain, or abnormal breath sounds), and radiographic pulmonary abnormalities that were at least segmental and were due to preexisting or other known causes. All cases of pneumonia occurring 3 days after hospitalization were considered nosocomial and were excluded. Microbiological Laboratory Tests Blood cultures and nasopharyngeal swab specimens were obtained from all patients at hospital admission and, if pleural fluid and sputum were available, a Gram stain test and a quantitative culture were obtained. Sputum data were only evaluated when the Gram stain test revealed numerous leukocytes ( 25 in a 100 microscopic field) and few squamous epithelial cells ( 10 in a 100 microscopic field). Certain invasive methods such as bronchoscopic examination were employed to obtain specimens in some patients after full explanation of the procedures. These specimens were also used for culturing of M pneumoniae and Legionella species on pleuropneumonia-like organism agar (70% Mycoplasma agar base [Becton Dickinson Microbiology Systems; Cockeysville, MD] 20% horse serum, 10% fresh yeast extract, thallium acetate [final concentration 0.5 mg/ml] and sterile penicillin G [final concentration 1,000 U/mL]) and buffered charcoal-yeast extract agar, respectively. Cultures for C pneumoniae and Chlamydia psittaci were performed in cycloheximide-treated HEp-2 cells grown in a 24-well cell culture plate. 5,16 All specimens were passed twice. Culture confirmation was done by fluorescent-antibody staining with C pneumoniae and C psittaci species-specific and genus-specific monoclonal antibodies. 5,16 Paired serum samples were collected at intervals of at least 4 weeks (range, 4 to 12 weeks; average, 6 weeks) after onset. Complement fixation tests were done in all patients for antibodies to influenza A and B viruses, adenovirus, respiratory syncytial virus, cytomegalovirus, parainfluenza virus types 1, 2 and 3, and M pneumoniae. Antibody to Legionella species was measured by the microagglutination test (detection of Legionella pneumophila serogroups 1 to 6, Legionella bozoemanii, Legionella dumoffii, Legionella gormanii, and Legionella micdadei) and Coxiella burnetii was measured by the indirect immunoflorescence test. The microimmunofluorescence test was used for titration of IgG and IgM antibodies against Chlamydial species, 3 using formalinized elementary bodies of C pneumoniae KK-pn15, Chlamydia trachomatis L2/434/Bu and C psittaci 6BC strains as antigens. Rheumatoid factors were absorbed with Gullsorb (Gull Laboratories; Salt Lake City, UT) before IgM titrations. In addition to serology and culturing, the urinary antigen test (Biotest; Dreieich, Germany) was used for detection of L pneumophila. Criteria for Determination of Microbial Etiology The microbial etiology was classified as definitive, presumptive, or unknown according to definitions established previously by Fang and colleagues. 10 Bacteria were considered to be definitive causative agents when isolated from blood or pleural fluid cultures. We considered the results of sputum cultures in combination with Gram stain findings. An organism showing heavy ( 10 7 cfu/ml) or moderate (10 6 cfu/ml) growth of a predominant bacterium on a sputum culture was considered to be a presumptive pathogen. Any microorganism isolated from BAL fluid was considered to be a presumptive pathogen when its concentration reached 10 5 cfu/ml in quantitative culture. If M pneumoniae or Legionella species was isolated from a specimen, that specimen was considered to be a definitive pathogen even if the culture showed little growth. L pneumophila was considered to be a presumptive agent when the urinary antigen test result was positive. For serologic tests, a fourfold rise in the antibody titer level between paired sera was considered definitive. Statistical Analysis Statistical analysis for the incidence of symptoms and laboratory data were done by Fisher exact test and the 2 test. A mean age comparison was done by the Student t test. CHEST / 121 / 6/ JUNE,

3 Results Clinical Presentation of CAP With Only One Pathogen Identified The patients who fulfilled the diagnostic criteria for pneumonia caused by C pneumoniae, S pneumoniae, or M pneumoniae without any evidence of other causative agents formed the groups for comparison of the clinical presentations. Among all CAP cases, there were 40 cases where C pneumoniae was the only pathogen identified by the panel of diagnostic tests used, 58 cases where S pneumoniae was identified, and 46 cases where M pneumoniae was identified. Of the 40 cases of C pneumoniae, 35 cases demonstrated fourfold or greater rises in IgG antibody titers, while 11 cases demonstrated fourfold or greater rises in IgM antibody titers (six cases met both criteria). All cases of M pneumoniae demonstrated fourfold antibody seroconversion (eight cases were culture positive). Table 1 shows the underlying conditions of the patients with the three etiologic agents of CAP. There were no statistically significant differences in terms of gender, smoking history, or underlying clinical diseases between the patients with C pneumoniae and those with S pneumoniae pneumonia, but the frequencies of a smoking history and underlying diseases of the patients with M pneumoniae pneumonia were significantly lower than those of C pneumoniae and S pneumoniae pneumonia. The mean age of the patients with S pneumoniae pneumonia (63.8 years) was significantly higher than that of patients with C pneumoniae (54.4 years, p 0.014) and M pneumoniae (35.3 years, p ) pneumonia. The mean age of the patients with C pneumoniae pneumonia was also significantly higher than that of patients with M pneumoniae (p ) pneumonia. Table 2 shows the major symptoms and physical findings at hospital admission. Among the respiratory symptoms, an important difference was observed between C pneumoniae and S pneumoniae pneumonia Table 1 Underlying Conditions of the Patients With the Major Three Etiologic Agents of CAP* Variables C pneumoniae S pneumoniae (n 58) M pneumoniae (n 46) Mean age (range), yr 54.4 (17 88) 63.8 (19 85) 35.3 (17 78) Male/female gender, 23/17 38/20 27/19 No. Smoking history 22 (55.0) 36 (62.0) 15 (32.6) COPD 4 (10.0) 9 (15.5) 0 Asthma 3 (7.5) 4 (6.8) 3 (6.5) Malignancy 3 (7.5) 3 (5.1) 0 No underlying disease 18 (45.0) 19 (32.7) 36 (78.2) *Data are presented as No. (%) unless otherwise indicated. with regard to dyspnea. The prevalence of shortness of breath in patients with S pneumoniae pneumonia was significantly higher than that in those with C pneumoniae (p 0.001) and M pneumoniae (p 0.000) pneumonia. The prevalence of CNS and GI symptoms was almost the same for C pneumoniae and S pneumoniae pneumonia. The average of maximum temperature during the first 24 h after hospital admission of C pneumoniae patients was 37.9 C, which was lower than that of S pneumoniae (38.7 C, p ) and M pneumoniae (39.0 C, p ) patients. The frequency of hypotension in the patients with S pneumoniae pneumonia was significantly higher than that in those with C pneumoniae (p 0.010) or M pneumoniae (p 0.040) pneumonia. Table 3 shows laboratory findings on hospital admission and prognostic factors. Both the mean WBC count and C-reactive protein (CRP) value on hospital admission were significantly higher in the patients with S pneumoniae pneumonia than those in the patients with C pneumoniae or M pneumoniae pneumonia (both, p ). The mean WBC count was higher in patients with C pneumoniae than that in patients with M pneumoniae pneumonia, but these data were not significant. In contrast, the mean serum level of glutamic pyruvic transaminase (GPT) was significantly higher in the patients with C pneumoniae and M pneumoniae pneumonia than in those with S pneumoniae pneumonia (vs C pneumoniae, p ; vs M pneumoniae, p ). No patients required respiratory support and/or admission to an ICU, and no patients died among those with C pneumoniae or M pneumoniae pneumonia. Therefore, the laboratory findings and prognostic factors were almost identical for C pneumoniae and M pneumoniae pneumonia. Clinical Presentation of Mixed C pneumoniae Pneumonia With Other Microorganisms: Among all of our CAP cases, C pneumoniae was identified as the etiologic agent in 62 cases. Of these, C pneumoniae was the only pathogen identified in 40 cases (64.5%), and one or more additional etiologic factors were found in 22 cases (35.5%). Of 22 cases of mixed C pneumoniae, 22 cases demonstrated fourfold or greater rises in IgG antibody titers, while three cases demonstrated fourfold or greater rises in IgM antibody titers. Table 4 shows the distribution of etiologies among the 22 cases of mixed C pneumoniae pneumonia. The most common additional pathogens were S pneumoniae (10 patients), followed by M pneumoniae (6 patients), and Haemophilus influenzae (6 patients). Among all the mixed C pneumoniae pneumonia cases, one additional 1778 Clinical Investigations

4 Table 2 Major Symptoms and Physical Findings at Hospital Admission of the Patients With the Major Three Etiologic Agents of CAP* Variables C pneumoniae S pneumoniae (n 58) M pneumoniae (n 46) Respiratory symptoms Cough 33 (82.5) 53 (91.3) 46 (100) Sputum production 27 (67.5) 48 (82.7) 28 (60.8) Hemoptysis 3 (7.5) 5 (8.6) 1 (2.1) Sore throat 10 (25.0) 11 (18.9) 18 (39.1) Shortness of breath 10 (25.0) 35 (60.3) 10 (21.7) Chest pain 7 (17.5) 13 (22.4) 8 (17.3) CNS symptoms Headache 10 (25.0) 8 (13.7) 16 (34.7) Confusion 3 (7.5) 4 (6.8) 1 (2.1) GI symptoms Nausea and/or vomiting 2 (5.0) 2 (3.4) 1 (2.1) Diarrhea 2 (5.0) 2 (3.4) 1 (2.1) Mean SD body temperature, C Hypotension 0 9 (15.5) 1 (2.1) *Data are presented as No. (%) unless otherwise indicated. The average of maximum temperature during the first 24 h after hospital admission. agent was found in 15 cases and two additional agents were found in 7 cases. Table 5 shows the clinical presentations of the CAP patients with mixed C pneumoniae with other microorganisms and those of patients with C pneumoniae with only one pathogen identified. There were many differences between these two groups, and the clinical presentations of cases of mixed C pneumoniae pneumonia with other bacteria, but not M pneumoniae, resembled those of cases with S pneumoniae pneumonia. Discussion Table 3 Laboratory Findings on Hospital Admission and Prognostic Factors of the Patients With the Major Three Etiologic Agents of CAP* Variables C pneumoniae S pneumoniae (n 58) M pneumoniae (n 46) WBC, 1,000/ L 9.1 ( ) 13.5 ( ) 7.5 ( ) CRP, mg/dl 10.6 ( ) 21.1 ( ) 12.0 ( ) GOT, IU/L 29.6 (8 77) 28.0 (12 86) 28.0 (8 85) GPT, IU/L 30.0 (11 84) 19.6 (8 68) 34.6 (9 162) Pao 2 60 mm Hg 10 (25.0) 32 (55.1) 6 (13.0) Na 131 meq/l 2 (5.0) 2 (3.4) 1 (2.1) Respiratory support 0 10 (17.2) 0 ICU admission 0 6 (10.3) 0 Mortality 0 3 (5.1) 0 *Data are presented as mean (range) or No. (%). GOT glutamic oxaloacetic transaminase. C pneumoniae was classified as a new Chlamydial species by Grayston and colleagues 3 in The diagnostic criteria for pneumonia caused by C pneumoniae are based on a fourfold or greater increase in the titer for any Ig class of antibodies to C pneumoniae between paired serum samples or an IgG titer of 1:512, or the presence of IgM ( 1:16) antibodies for any serum sample examined by the microimmunofluorescence test. 3,4 The diagnosis of C pneumoniae pneumonia in previous reports 9 15 was also based on these criteria. In addition, Kauppinen et al 13 and Lieberman et al 14 included a high IgA titer as one of the diagnostic criterion of acute C pneumoniae pneumonia. However, criteria using single serum antibodies, IgG 1:512 and IgM 1: 16, are a controversial issue because a high incidence of IgG 1:512 or IgM 1:16 has been seen among healthy asymptomatic subjects, and we also made the same observation. 20 Also, criteria for definition of IgA levels as indicative of acute infection have not been established. In this study, therefore, we excluded the IgG titer 1:512, IgM titer 1:16, and IgA titer from our diagnostic criteria. Table 4 Frequency Distribution of Additional Etiologies of CAP in 62 Patients Infected With C pneumoniae* Pathogens No. (%) S pneumoniae 10 (16.1) M pneumoniae 6 (9.7) H influenzae 6 (9.7) Staphylococcus aureus 4 (6.5) Moraxelle catarrhalis 2 (3.2) L pneumophila 1 (1.6) Single agent 40 (64.5) *One or more additional agents were found in 22 cases (7 cases had infections with two pathogens). C pneumoniae was only pathogen identified. CHEST / 121 / 6/ JUNE,

5 Table 5 Characteristics of the 62 Patients With C pneumoniae Pneumonia* Characteristics Only One Pathogen Was Identified Concomitant Infection With M pneumoniae (n 5) Concomitant Infection With Bacteria (n 17) Age, yr 54.4 (17 88) 25.8 (17 30) 69.5 (35 88) Male/female gender 23/17 2/3 12/5 No underlying disease Respiratory symptoms Cough Sputum production Shortness of breath CNS symptoms Headache Confusion Mean SD temperature, C WBC, 1,000/ L 9.1 ( ) 8.0 ( ) 15.6 ( ) CRP, mg/dl 10.6 ( ) 10.8 ( ) 22.8 ( ) GOT, IU/L 29.6 (8 77) 33.2 (10 76) 28.4 (8 80) GPT, IU/L 30.0 (11 84) 36.8 (10 124) 22.3 (12 72) Pao 2 60 mm Hg Mortality *Data are presented as mean (range) or No. unless otherwise indicated. See Table 3 for expansion of abbreviation. Including one pneumonia patient with C pneumoniae, M pneumoniae, and S pneumoniae. Furthermore, C pneumoniae has been reported to cause pneumonia frequently in association with other respiratory pathogens, mainly S pneumoniae. 8,9,12 15,21 In our study, about 35% of the C pneumoniae pneumonia case-patients had a concomitant infection with other microorganisms. It has been noted that the clinical presentations of CAP cases with multiple pathogens and cases where C pneumoniae was the only pathogen identified differ. 13 We also confirmed this observation in the present study (Table 5). In addition, it has been suggested that mixed cases of mild or asymptomatic upper respiratory tract infections are probably induced by C pneumoniae and are followed by secondary bacterial pneumonia due to another proven etiology. Therefore, we also excluded mixed C pneumoniae pneumonia in this study in order to analyze the clinical presentations of pneumonia cases with C pneumoniae as the only pathogen identified. Among clinical symptoms, it has been reported that CNS symptoms including headache seem to be common in patients with C pneumoniae pneumonia Blasi et al 11 and Kauppinen et al 13 reported that 43 to 46% of their case-patients experienced headache. Further, Fang et al 10 and Sundelöf etal 12 reported that 38 to 45% of their case-patients experienced changes in mental status. In our study, 25% of case-patients had headaches and 7% had confusion. Therefore, the frequency of CNS symptoms was lower than that in previous reports. The difference may be due to the demographic factors, particularly age (the mean age of the study population was older in previous studies than in our study). In addition, no significant differences were found in clinical symptoms, except for shortness of breath, among the patients with C pneumoniae, S pneumoniae, and M pneumoniae pneumonia. Among laboratory findings, elevated WBC counts have been reported in association with C pneumoniae pneumonia. 9,10,13 15 However, this finding was not evident in the study by Blasi et al 11 or in our patients, although a high WBC count (mean 15,600/ L) was seen in patients with mixed C pneumoniae pneumonia with other bacteria (Table 5). Elevated levels of alkaline phosphatase have also been documented in association with C pneumoniae pneumonia, 12 but not in our study or other previous reports. 9 11,13,14 The relatively slow pulse rate in relation to the fever reported in association with other intracellular infections such as legionellosis and psittacosis was not seen in our patients with C pneumoniae pneumonia, and this result was consistent with the data of Kauppinen et al. 13 Analysis of the age distribution of CAP patients in our study showed that while CAP affects adults of all ages, the mean age of patients with C pneumoniae pneumonia is significantly higher than that of those with M pneumoniae pneumonia and lower than that of patients with S pneumoniae pneumonia. Our results also showed that the mean age of patients with single agent C pneumoniae pneumonia was significantly lower than that of those with mixed C pneumoniae pneumonia, with the exception of those with a concomitant infection with M pneumoniae (54.4 vs 69.5, p 0.003). Therefore, the highest incidence of C pneumoniae pneumonia ob Clinical Investigations

6 served among the elderly people in previous reports 9,10,12 may reflect concomitant infection with other microorganisms. Recently, Lim et al 22 reported that they found C pneumoniae to be more common in the winter than in the summer (p 0.015). In this study, however, we could not detect any evidence of seasonality during a 5-year period. The difference may be due to the fact that the data in the study by Lim et al 22 covered only one winter period. In conclusion, our results indicate that C pneumoniae pneumonia as a single etiologic agent is mild and that the underlying conditions and clinical symptoms closely resemble those of S pneumoniae pneumonia. However, the results of physical examinations, laboratory findings, and the prognostic factors of C pneumoniae resemble those of M pneumoniae pneumonia. References 1 Health and Welfare Statistics Association of Japan. Annual report of national health and hygiene in Japan [in Japanese]. Kousei No Shihyo 2000; 47:S396 S420 2 Basic management of community-acquired pneumonia in adults. In: Matsushima T, Kohno S, Saito A, et al, eds. Guidelines for the management of respiratory tract infection. Tokyo, Japan: The Japanese Respiratory Society, 2000; Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: Kuo CC, Jackson LA, Campbell LA, et al. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: Miyashita N, Kubota Y, Nakajima M, et al. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 1998; 80: Miyashita N, Niki Y, Nakajima M, et al. Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD. Chest 1998; 114: Ishida T, Hashimoto T, Arita M, et al. Multicenter screening of Chlamydia pneumoniae pneumonia by ELISA method [in Japanese]. Jpn J Assoc Infect Dis 1999; 73: Miyashita N, Fukano H, Niki Y, et al. Etiology of communityacquired pneumonia requiring hospitalization in Japan. Chest 2001; 119: Marrie TJ, Grayston JT, Wang SP, et al. Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med 1987; 106: Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore) 1990; 69: Blasi F, Cosentini R, Legnani D, et al. Incidence of communityacquired pneumonia caused by Chlamydia pneumoniae in Italian patients. Eur J Clin Microbiol Infect Dis 1993; 12: Sundelöf B, Gnarpe J, Gnarpe H, et al. Chlamydia pneumoniae in Swedish patients. Scand J Infect Dis 1993; 25: Kauppinen MT, Saikku P, Kujala P, et al. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996; 51: Lieberman D, Ben-Yaakov M, Lazarovich Z, et al. Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients. Infection 1996; 24: Steinhoff D, Lode H, Ruckdeschel G, et al. Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis 1996; 22: Miyashita N, Matsumoto A, Soejima R, et al. Evaluation of a direct fluorescent antibody assay for detection of Chlamydia pneumoniae. Jpn J Assoc Infect Dis 1996; 70: Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994; 32: Hyman CL, Roblin PM, Gaydos CA, et al. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995; 20: Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Chest 1993; 104: Miyashita N, Niki Y, Nakajima M, et al. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 2001; 119: Kauppinen MT, Herva E, Kujala P, et al. The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 1995; 172: Lim WS, Macfarlane JT, Boswell TCJ, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56: CHEST / 121 / 6/ JUNE,

Chlamydia pneumoniae infection in adult patients with persistent cough

Chlamydia pneumoniae infection in adult patients with persistent cough Journal of Medical Microbiology (2003), 52, 265 269 DOI 10.1099/jmm.0.04986-0 Chlamydia pneumoniae infection in adult patients with persistent cough Naoyuki Miyashita, Hiroshi Fukano, Koichiro Yoshida,

More information

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory

More information

Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome

Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome J Microbiol Immunol Infect 2005;38:117-122 Tsai et al Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome Ming-Han Tsai 1, Yhu-Chering Huang 1, Chih-Jung

More information

Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study

Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study Journal of Medical Microbiology (2005), 54, 395 400 DOI 10.1099/jmm.0.45920-0 Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study Naoyuki Miyashita, Hiroshi Fukano,

More information

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents Objectives Atypical Pneumonia K. Sue Kehl, Ph.D., D(ABMM) Associate Professor, Pathology Medical College of Wisconsin Associate Director of Clinical Pathology & Technical Director of Microbiology, Children's

More information

Evaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella

Evaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella JCM Accepts, published online ahead of print on 6 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00397-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Key words: Chlamydia pneumoniae, acute upper resiratory infections, culture, micro-if method

Key words: Chlamydia pneumoniae, acute upper resiratory infections, culture, micro-if method Key words: Chlamydia pneumoniae, acute upper resiratory infections, culture, micro-if method Table 1 Prevalence of antibodies to C. pneumoniae in patients and control group There was no statistically significant

More information

Pneumonia with Serological Evidence of Acute Infection with the Chlamydia-like Microorganism Z

Pneumonia with Serological Evidence of Acute Infection with the Chlamydia-like Microorganism Z Pneumonia with Serological Evidence of Acute Infection with the Chlamydia-like Microorganism Z DAVID LIEBERMAN, SIMONA KAHANE, DEVORA LIEBERMAN, and MAUREEN G. FRIEDMAN Pulmonary Unit, Division of Internal

More information

Microbiology of Atypical Pneumonia. Dr. Mohamed Medhat Ali

Microbiology of Atypical Pneumonia. Dr. Mohamed Medhat Ali Microbiology of Atypical Pneumonia Dr. Mohamed Medhat Ali Pneumonia P n e u m o n i a i s a n infection of the lungs that can be caused by viruses, bacteria, and fungi. Atypical! Pneumonia Symptoms. X-ray

More information

ORIGINAL ARTICLE /j x

ORIGINAL ARTICLE /j x ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01898.x Acute Chlamydia pneumoniae infections in asthmatic and non-asthmatic military conscripts during a non-epidemic period R. Juvonen 1, A. Bloigu 2, M. Paldanius

More information

PNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality

PNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality Page 1 of 8 September 4, 2001 Donald P. Levine, M.D. University Health Center Suite 5C Office: 577-0348 dlevine@intmed.wayne.edu Assigned reading: pages 153-160; 553-563 PNEUMONIA the most widespread and

More information

Outbreak of Respiratory Tract Infections on an Islet in Korea: Possible Chlamydia pneumoniae Infection

Outbreak of Respiratory Tract Infections on an Islet in Korea: Possible Chlamydia pneumoniae Infection Jpn. J. Infect. Dis., 59, 294-298, 2006 Original Article Outbreak of Respiratory Tract Infections on an Islet in Korea: Possible Chlamydia pneumoniae Infection Kwang-Jun Lee, Su-Jin Kwon, Bo-Ram Choi,

More information

Importance of Atypical Pathogens of Community-Acquired Pneumonia

Importance of Atypical Pathogens of Community-Acquired Pneumonia S35 Importance of Atypical Pathogens of Community-Acquired Pneumonia Joseph F. Plouffe Departments of Internal Medicine and Medical Microbiology and Immunology, Ohio State University College of Medicine,

More information

Unit II Problem 2 Microbiology Lab: Pneumonia

Unit II Problem 2 Microbiology Lab: Pneumonia Unit II Problem 2 Microbiology Lab: Pneumonia - What are the steps needed to obtain a proper sputum specimen? You need the following: A wide-mouth labeled container. Gloves. Water. Mouth wash + tissues.

More information

Outbreak of Pertussis in a University Laboratory

Outbreak of Pertussis in a University Laboratory ORIGINAL ARTICLE Outbreak of Pertussis in a University Laboratory Naoyuki Miyashita 1, Yasuhiro Kawai 2, Tetsuya Yamaguchi 2, Kazunobu Ouchi 2, Koji Kurose 3 and Mikio Oka 3 Abstract Objective Analysis

More information

Serological evidence of Legionella species infection in acute exacerbation of COPD

Serological evidence of Legionella species infection in acute exacerbation of COPD Eur Respir J 2002; 19: 392 397 DOI: 10.1183/09031936.02.00256702 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Serological evidence of Legionella

More information

PNEUMONIA IN CHILDREN. IAP UG Teaching slides

PNEUMONIA IN CHILDREN. IAP UG Teaching slides PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children

More information

prospective study among adults requiring

prospective study among adults requiring Thorax 1995;50:543-547 Department of Infectious Diseases, University Hospital, Building 1, C5-P, PO Box 9600, 2300 RC Leiden, The Netherlands R Bohte R van Furth P J van den Broek Reprint requests to:

More information

Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?

Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? David L Hahn, MD, MS* and Roberta McDonald, BS Background: Chlamydia pneumoniae infection can cause acute respiratory

More information

KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA

KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA Methodology: Expert opinion Issue Date: 8-97 Champion: Pulmonary Medicine Most Recent Update: 6-08, 7-10, 7-12 Key Stakeholders: Pulmonary Medicine,

More information

Upper...and Lower Respiratory Tract Infections

Upper...and Lower Respiratory Tract Infections Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University

More information

Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR (1167)

Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR (1167) From the Japanese Association of Medical Sciences The Japanese Association for Infectious Diseases Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR

More information

The McMaster at night Pediatric Curriculum

The McMaster at night Pediatric Curriculum The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives

More information

Chlamydia MIF IgM. Performance Characteristics. Product Code IF1250M Rev. I. Not for Distribution in the United States

Chlamydia MIF IgM. Performance Characteristics. Product Code IF1250M Rev. I. Not for Distribution in the United States Product Code IF1250M Rev. I Performance Characteristics Not for Distribution in the United States EXPECTED VALUES Community Acquired Pneumonia Population Two outside investigators assessed the Focus Chlamydia

More information

Antimicrobial Stewardship in Community Acquired Pneumonia

Antimicrobial Stewardship in Community Acquired Pneumonia Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis

More information

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines 296 Respiratory Infection Research Group, Respiratory Medicine, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK W S Lim J T Macfarlane Department of Medical Microbiology T C J Boswell Department

More information

2009 (Pandemic) H1N1 Influenza Virus

2009 (Pandemic) H1N1 Influenza Virus 2009 (Pandemic) H1N1 Influenza Virus September 15, 2009 Olympia, Washington Anthony A Marfin Washington State Department of Health Goals Understand current situation & pattern of transmission of 2009 H1N1

More information

an inflammation of the bronchial tubes

an inflammation of the bronchial tubes BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious

More information

Pneumonia. Definition of pneumonia Infection of the lung parenchyma Usually bacterial

Pneumonia. Definition of pneumonia Infection of the lung parenchyma Usually bacterial Pneumonia Definition of pneumonia Infection of the lung parenchyma Usually bacterial Epidemiology of pneumonia Commonest infectious cause of death in the UK and USA Incidence - 5-11 per 1000 per year Worse

More information

Risk Factor Analysis of Acute Respiratory Distress Syndrome Among Hospitalized Patients with Chlamydophila pneumoniae Pneumonia

Risk Factor Analysis of Acute Respiratory Distress Syndrome Among Hospitalized Patients with Chlamydophila pneumoniae Pneumonia ORIGINAL ARTICLE Risk Factor Analysis of Acute Respiratory Distress Syndrome Among Hospitalized Patients with Chlamydophila pneumoniae Pneumonia Kuan-Ting Liu 1,2, Kuang-Yao Yang 1,3 *, Yu-Chin Lee 1,

More information

Chlamydia MIF IgG. Performance Characteristics. Product Code IF1250G Rev. J. Not for Distribution in the United States

Chlamydia MIF IgG. Performance Characteristics. Product Code IF1250G Rev. J. Not for Distribution in the United States Product Code IF1250G Rev. J Performance Characteristics Not for Distribution in the United States EXPECTED VALUES Community Acquired Pneumonia Population Two outside investigators assessed the Focus Chlamydia

More information

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? David Murdoch Department of Pathology University of Otago, Christchurch Outline Background Diagnostic challenges

More information

INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)

INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases) INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases) 1. Agent: Influenza viruses A, B, and C. Only influenza A and B are of public health concern since they are responsible for epidemics. 2. Identification:

More information

Two Cases of Acute Respiratory Distress Syndrome with High Values of Chlamydophila pneumoniae-specific Antibodies

Two Cases of Acute Respiratory Distress Syndrome with High Values of Chlamydophila pneumoniae-specific Antibodies CASE REPORT Two Cases of Acute Respiratory Distress Syndrome with High Values of Chlamydophila pneumoniae-specific Antibodies Ryotaro Igusa 1, Atsushi Nakamura 1, Sachiko Kawana 1, Taizou Shibahara 2,

More information

A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia

A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia Eur Respir J 2001; 18: 362 368 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 A prospective comparison of nursing home acquired pneumonia

More information

point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital

point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital laboratory performed by a health care professional or non-medical

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

Key words: bacteremia; community-acquired pneumonia; comorbid condition; diabetes mellitus; empyema; etiology; outcome; pleural effusion

Key words: bacteremia; community-acquired pneumonia; comorbid condition; diabetes mellitus; empyema; etiology; outcome; pleural effusion Etiology and Outcome of Community- Acquired Pneumonia in Patients With Diabetes Mellitus* Miquel Falguera, MD; Ricard Pifarre, MD; Antonio Martin, MD; Anas Sheikh, MD; and Anna Moreno, MD Study objectives:

More information

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults Eur Respir J 2003; 21: 209 214 DOI: 10.1183/09031936.03.00058802 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Rapid urinary antigen test

More information

Comparison of Five Serologic Tests for Diagnosis of Acute Infections by Chlamydia pneumoniae

Comparison of Five Serologic Tests for Diagnosis of Acute Infections by Chlamydia pneumoniae CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2000, p. 739 744 Vol. 7, No. 5 1071-412X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Comparison of Five Serologic

More information

A Study of Prognosis and Outcome of Community Acquired Pneumonia in a Tertiary Care Centre

A Study of Prognosis and Outcome of Community Acquired Pneumonia in a Tertiary Care Centre ISSN: 2319-7706 Volume 4 Number 8 (2015) pp. 763-769 http://www.ijcmas.com Original Research Article A Study of Prognosis and Outcome of Community Acquired Pneumonia in a Tertiary Care Centre Bhadra Reddy

More information

Clinical Comparative Study of Sulbactam/Ampicillin and Imipenem/Cilastatin in Elderly Patients with Community-Acquired Pneumonia

Clinical Comparative Study of Sulbactam/Ampicillin and Imipenem/Cilastatin in Elderly Patients with Community-Acquired Pneumonia ORIGINAL ARTICLE Clinical Comparative Study of Sulbactam/Ampicillin and Imipenem/Cilastatin in Elderly Patients with Community-Acquired Pneumonia Katsunori Yanagihara 1,2, Yuichi Fukuda 1, Masafumi Seki

More information

The Microimmunofluorescence Test for Chlamydia pneumoniae Infection: Technique and Interpretation

The Microimmunofluorescence Test for Chlamydia pneumoniae Infection: Technique and Interpretation S421 The Microimmunofluorescence Test for Chlamydia pneumoniae Infection: Technique and Interpretation San-pin Wang Department of Pathobiology, University of Washington, Seattle A brief description of

More information

Središnja medicinska knjižnica

Središnja medicinska knjižnica Središnja medicinska knjižnica Puljiz, I., Kuzman, I., Đaković-Rode, O., Schonwald, N., Miše, B. (2006) Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Blum CA, Nigro N, Briel M, et al. Adjunct prednisone

More information

Upper Respiratory Infections. Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University

Upper Respiratory Infections. Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University Upper Respiratory Infections Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University Disclosures None Objectives Know the common age- and season-specific causes of pharyngitis

More information

Toshio Kishimoto*, Shuji Ando, Kei Numazaki 1, Kazunobu Ouchi 2, Tsutomu Yamazaki 3, and Chikara Nakahama 4

Toshio Kishimoto*, Shuji Ando, Kei Numazaki 1, Kazunobu Ouchi 2, Tsutomu Yamazaki 3, and Chikara Nakahama 4 Jpn. J. Infect. Dis., 62, 260-264, 2009 Original Article Assay of Chlamydia pneumoniae-specific IgM Antibodies by ELISA Method---Reduction of Non-Specific Reaction and Resetting of Serological Criteria

More information

Making the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP?

Making the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP? Making the Right Call With Community-Acquired Pneumonia In this article: By Thomas J. Marrie, MD The case of Allyson Allyson, 32, presented to the emergency department with a 48-hour history of anorexia,

More information

Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical

Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical Thorax 1989;44:1031-1035 Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features Prepared on behalf of the British Thoracic Society Pneumonia Research

More information

Viral Infection. Pulmonary Infections with Respiratory Viruses. Wallace T. Miller, Jr., MD. Objectives: Viral Structure: Significance:

Viral Infection. Pulmonary Infections with Respiratory Viruses. Wallace T. Miller, Jr., MD. Objectives: Viral Structure: Significance: Viral Infection Wallace T. Miller, Jr., MD Pulmonary Infections with Respiratory Viruses Wallace T. Miller, Jr. MD Associate Professor of Radiology and Pulmonary and Critical Care Medicine University of

More information

Lecture Notes. Chapter 16: Bacterial Pneumonia

Lecture Notes. Chapter 16: Bacterial Pneumonia Lecture Notes Chapter 16: Bacterial Pneumonia Objectives Explain the epidemiology Identify the common causes Explain the pathological changes in the lung Identify clinical features Explain the treatment

More information

Respiratory Pathogen Panel TEM-PCR Test Code:

Respiratory Pathogen Panel TEM-PCR Test Code: Respiratory Pathogen Panel TEM-PCR Test Code: 220000 Tests in this Panel Enterovirus group Human bocavirus Human coronavirus (4 types) Human metapneumovirus Influenza A - Human influenza Influenza A -

More information

Received 3 August 2005/Returned for modification 13 September 2005/Accepted 13 January 2006

Received 3 August 2005/Returned for modification 13 September 2005/Accepted 13 January 2006 CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2006, p. 361 364 Vol. 13, No. 3 1556-6811/06/$08.00 0 doi:10.1128/cvi.13.3.361 364.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Evaluation

More information

in the study. All patients had a history of acute to be caused by pulmonary embolism, bronchopulmonary

in the study. All patients had a history of acute to be caused by pulmonary embolism, bronchopulmonary Thorax 1981 ;36:566-570 Causes of pneumonia presenting to a district general hospital RJ WHITE, AD BLAINEY, K JOY HARRISON, SKR CLARKE From the Departments of Medicine and Bacteriology, Frenchay Hospital,

More information

ELISA test to detect Chlamydophila pneumoniae IgG

ELISA test to detect Chlamydophila pneumoniae IgG J. Basic Microbiol. 42 (2002) 1, 13 18 (Departments of Microbiology and Surgery 1, University Hospital San Cecilio, University of Granada, School of Medicine, Granada, Spain) ELISA test to detect Chlamydophila

More information

Unit II Problem 2 Pathology: Pneumonia

Unit II Problem 2 Pathology: Pneumonia Unit II Problem 2 Pathology: Pneumonia - Definition: pneumonia is the infection of lung parenchyma which occurs especially when normal defenses are impaired such as: Cough reflex. Damage of cilia in respiratory

More information

Microbial aetiology of community-acquired pneumonia and its relation to severity

Microbial aetiology of community-acquired pneumonia and its relation to severity < Additional data are published online only. To view these files please visit the journal online (http://thorax.bmj.com). 1 Servei de Pneumologia, Institut del Tòrax, Hospital Clinic, IDIBAPS, Universitat

More information

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory

More information

MICROBIOLOGICAL TESTING IN PICU

MICROBIOLOGICAL TESTING IN PICU MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes

More information

MAJOR ARTICLE. Beatriz Rosón, 1 Jordi Carratalà, 1 Jordi Dorca, 2 Aurora Casanova, 3 Frederic Manresa, 2 and Francesc Gudiol 1

MAJOR ARTICLE. Beatriz Rosón, 1 Jordi Carratalà, 1 Jordi Dorca, 2 Aurora Casanova, 3 Frederic Manresa, 2 and Francesc Gudiol 1 MAJOR ARTICLE Etiology, Reasons for Hospitalization, Risk Classes, and Outcomes of Community-Acquired Pneumonia in Patients Hospitalized on the Basis of Conventional Admission Criteria Beatriz Rosón, 1

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients

More information

Clinical Features of Mycoplasmal Pneumonia in Adults

Clinical Features of Mycoplasmal Pneumonia in Adults THE YALE JOURNAL OF BIOLOGY AND MEDICINE 56 (1983), 505-510 Clinical Features of Mycoplasmal Pneumonia in Adults KINICHI IZUMIKAWA, M.D., AND KOHEI HARA, M.D. Second Department of Internal Medicine, Nagasaki

More information

Association of Chlamydia pneumoniae IgA antibodies with

Association of Chlamydia pneumoniae IgA antibodies with Epidemiol. Infect. (1996), 117, 513-517 Copyright K 1996 Cambridge University Press Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma D. L. HAHN'*, T. ANTTILA AND P. SAIKKU2'3

More information

A New Primer Pair for Detection of Chiamydia pneumoniae by Polymerase Chain Reaction

A New Primer Pair for Detection of Chiamydia pneumoniae by Polymerase Chain Reaction A New Primer Pair for Detection of Chiamydia pneumoniae by Polymerase Chain Reaction Microbiol. Immunol., 40(1), 27-32, 1996 Yoshifumi Kubota Division of Respiratory Diseases, Department of Medicine, Kawasaki

More information

Pathogensinvolved in lower respiratorytract infectionsin generalpractice

Pathogensinvolved in lower respiratorytract infectionsin generalpractice Chapter III Pathogensinvolved in lower respiratorytract infectionsin generalpractice AW Graffelman, A Knuistingh Neven, S le Cessie, ACM Kroes, MP Springer, PJvan den Broek British Journal of General Practice

More information

ETIOLOGIES AND TREATMENT OUTCOMES IN PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) AT SRINAGARIND HOSPITAL, KHON KAEN, THAILAND

ETIOLOGIES AND TREATMENT OUTCOMES IN PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) AT SRINAGARIND HOSPITAL, KHON KAEN, THAILAND SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH ETIOLOGIES AND TREATMENT OUTCOMES IN PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) AT SRINAGARIND HOSPITAL, KHON KAEN, THAILAND Wipa Reechaipichitkul

More information

Babak Valizadeh, DCLS

Babak Valizadeh, DCLS Laboratory Diagnosis of Bacterial Infections of the Respiratory Tract Babak Valizadeh, DCLS 1391. 02. 05 2012. 04. 25 Babak_Valizadeh@hotmail.com Biological Safety Cabinet Process specimens in biological

More information

Mædica - a Journal of Clinical Medicine

Mædica - a Journal of Clinical Medicine Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Mortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients Cornelia TUDOSE, Assistant Professor of Pneumology;

More information

Emerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington

Emerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington Emerging Respiratory Infections NZ 2015 Amanda McNaughton Respiratory Physician CCDHB Wellington Respiratory Infection: overview Influenza virus Clinical picture Emerging infection New Zealand Influenza

More information

Downloaded from:

Downloaded from: Muller-Pebody, B; Crowcroft, NS; Zambon, MC; Edmunds, WJ (2006) Modelling hospital admissions for lower respiratory tract infections in the elderly in England. Epidemiology and infection, 134 (6). pp.

More information

THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE

THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE The following content is provided for informational purposes only. PREVENTION AND CONTROL OF INFLUENZA Lisa McHugh, MPH Influenza can be a serious

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Microbiology Department Crawley Hospital West Green Drive Crawley RH11 7DH United Kingdom Contact: Clare Reynolds Tel: +44 (0) 1293 600379

More information

- Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including

- Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including KHOA DICH VU HO HAP - Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including wheezing, coryza, bronchopneumonia. -

More information

Evaluation of sensitivity of two serological tests for diagnosing pneumonia caused by Legionella

Evaluation of sensitivity of two serological tests for diagnosing pneumonia caused by Legionella J Clin Pathol 1987;40:77-82 Evaluation of sensitivity of two serological tests for diagnosing pneumonia caused by Legionella pneumophila serogroup 1 T G HARRSON,* E DOURNON,t A G TAYLOR* From the *Division

More information

Current and Emerging Legionella Diagnostics

Current and Emerging Legionella Diagnostics Current and Emerging Legionella Diagnostics Nicole Wolter Centre for Respiratory Diseases and Meningitis (CRDM) National Institute for Communicable Diseases nicolew@nicd.ac.za 7 th FIDSSA Conference, Cape

More information

Appendix B: Provincial Case Definitions for Reportable Diseases

Appendix B: Provincial Case Definitions for Reportable Diseases Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Influenza Revised December 2014 Influenza 1.0 Provincial Reporting Confirmed cases of disease 2.0 Type

More information

Pneumococcal pneumonia

Pneumococcal pneumonia Pneumococcal pneumonia Wei Shen Lim Consultant Respiratory Physician & Honorary Professor of Medicine Nottingham University Hospitals NHS Trust University of Nottingham Declarations of interest Unrestricted

More information

Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults

Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults Respiratory Medicine (2006) 100, 884 891 Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults Felipe Andreo a,, José Domínguez b, Juan Ruiz a, Silvia

More information

Community Acquired Pneumonia

Community Acquired Pneumonia April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of

More information

Pneumonia. Dr. Rami M Adil Al-Hayali Assistant professor in medicine

Pneumonia. Dr. Rami M Adil Al-Hayali Assistant professor in medicine Pneumonia Dr. Rami M Adil Al-Hayali Assistant professor in medicine Definition Pneumonia is an acute respiratory illness caused by an infection of the lung parenchyma, associated with recently developed

More information

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes

More information

THE PHARMA INNOVATION - JOURNAL Acute exacerbation of chronic obstructive pulmonary disease, caused by viruses: the need of combined antiinfective

THE PHARMA INNOVATION - JOURNAL Acute exacerbation of chronic obstructive pulmonary disease, caused by viruses: the need of combined antiinfective Received: 19-11-2013 Accepted: 28-12-2013 ISSN: 2277-7695 CODEN Code: PIHNBQ ZDB-Number: 2663038-2 IC Journal No: 7725 Vol. 2 No. 11. 2014 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION

More information

COPD exacerbation. Dr. med. Frank Rassouli

COPD exacerbation. Dr. med. Frank Rassouli Definition according to GOLD report: - «An acute event - characterized by a worsening of the patients respiratory symptoms - that is beyond normal day-to-day variations - and leads to a change in medication»

More information

1/9/ :00:00AM 1/9/ :40:15AM 6/9/2017 9:19:16AM A/c Status. Test Name Results Units Bio. Ref. Interval. Nasal Swab

1/9/ :00:00AM 1/9/ :40:15AM 6/9/2017 9:19:16AM A/c Status. Test Name Results Units Bio. Ref. Interval. Nasal Swab LL - LL-ROHINI (NATIONAL REFERENCE 135091523 Age 36 Years Gender Female 1/9/2017 120000AM 1/9/2017 114015AM 6/9/2017 91916AM Ref By Final RESIRATORY COMREHENSIVE ANEL (33 ATHOGENS) RESIRATORY ANEL 1 #

More information

Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults

Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults International Journal of Infectious Diseases (2005) 9, 274 279 http://intl.elsevierhealth.com/journals/ijid Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract

More information

(CAP) CAP CAP. (RVs) (PV) (RV + ) CAP. RVs ( CAP [2 / 26 (8%) P = 0.035] CAP [1 / 44 (2%) P = 0.001] P = 0.024] 26 (31%)]

(CAP) CAP CAP. (RVs) (PV) (RV + ) CAP. RVs ( CAP [2 / 26 (8%) P = 0.035] CAP [1 / 44 (2%) P = 0.001] P = 0.024] 26 (31%)] Andrés de Roux, MD; Maria A. Marcos, MD; Elisa Garcia, MD; Jose Mensa, MD; Santiago Ewig, MD, PhD; Hartmut Lode, MD, PhD; and Antoni Torres, MD, PhD, FCCP (CAP) CAP 1996 2001, 1 000 338 CAP (RVs) (PV)

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Identification of Microorganisms Using Nucleic Acid Probes File Name: Origination: Last CAP Review: Next CAP Review: Last Review: identification_of_microorganisms_using_nucleic_acid_probes

More information

Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia

Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia ORIGINAL ARTICLE Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia Chiung-Zuei Chen, 1 Po-Sheng Fan, 2 Chien-Chung

More information

X/01/$ DOI: /CDLI Received 6 November 2000/Returned for modification 6 February 2001/Accepted 27 February 2001

X/01/$ DOI: /CDLI Received 6 November 2000/Returned for modification 6 February 2001/Accepted 27 February 2001 CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, May 2001, p. 588 592 Vol. 8, No. 3 1071-412X/01/$04.00 0 DOI: 10.1128/CDLI.8.3.588 592.2001 Comparison of Two Commercial Microimmunofluorescence Kits and

More information

CHLAMYDOPHILA PNEUMONIAE IFA SLIDE

CHLAMYDOPHILA PNEUMONIAE IFA SLIDE 0318 1 Humid chamber. VIRCELL IFA kit of the corresponding specificity. CHLAMYDOPHILA PNEUMONIAE IFA SLIDE SCHPN: Slides for the diagnosis of Chlamydophila pneumoniae antibodies in human serum by indirect

More information

Chlamydia group: That is because:

Chlamydia group: That is because: Chlamydia group: We will start by saying that it is the causative agent of respiratory tract infections, especially lower respiratory tract infections. It is a special group of microorganisms because this

More information

Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital

Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital 101 Research article Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital Abstract BN Dissanayake 1,, DE Jayawardena 2, CG Senevirathna 1, TM Gamage 1 Sri Lankan Journal

More information

PNEUMONIA IN A PRESUMED IMMUNOCOMPETENT PATIENT

PNEUMONIA IN A PRESUMED IMMUNOCOMPETENT PATIENT Dr Marie Bruyneel and Deborah Konopnicki BVIKM/SBMIC November 8th, 2012 PNEUMONIA IN A PRESUMED IMMUNOCOMPETENT PATIENT Men, 54 years Emergency room on end october 2009 Sent by his family doctor for Influenza

More information

Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance

Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance 10 July 2009 Background This document updates the interim WHO guidance on global surveillance of pandemic

More information

Clinical Characteristics of Nursing and Healthcare-Associated Pneumonia: A Japanese Variant of Healthcare-Associated Pneumonia

Clinical Characteristics of Nursing and Healthcare-Associated Pneumonia: A Japanese Variant of Healthcare-Associated Pneumonia ORIGINAL ARTICLE Clinical Characteristics of Nursing and Healthcare-Associated Pneumonia: A Japanese Variant of Healthcare-Associated Pneumonia Tadashi Ishida, Hiromasa Tachibana, Akihiro Ito, Hiroshige

More information

Evaluation of PCR, Culture, and Serology for Diagnosis of Chlamydia pneumoniae Respiratory Infections

Evaluation of PCR, Culture, and Serology for Diagnosis of Chlamydia pneumoniae Respiratory Infections JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1998, p. 2301 2307 Vol. 36, No. 8 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Evaluation of PCR, Culture, and Serology

More information

Chapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews

Chapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews Chapter 10 Respiratory System J00-J99 Presented by: Jesicca Andrews 1 Respiratory System 2 Respiratory Infections A respiratory infection cannot be assumed from a laboratory report alone; physician concurrence

More information